{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:39:09Z","timestamp":1788381549849,"version":"build-2803163510"},"reference-count":74,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006984","name":"Irma T. Hirschl Trust","doi-asserted-by":"publisher","award":["102217"],"award-info":[{"award-number":["102217"]}],"id":[{"id":"10.13039\/100006984","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Colton family","award":["43989"],"award-info":[{"award-number":["43989"]}]},{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","award":["103486"],"award-info":[{"award-number":["103486"]}],"id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01AI125640"],"award-info":[{"award-number":["R01AI125640"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.autrev.2017.05.025","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T12:46:46Z","timestamp":1496148406000},"page":"767-773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Targeting the programmed cell death-1 pathway in rheumatoid arthritis"],"prefix":"10.1016","volume":"16","author":[{"given":"Sabina","family":"Sandigursky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg J.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Mor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6937","key":"10.1016\/j.autrev.2017.05.025_bb0005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.autrev.2017.05.025_bb0010","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.autrev.2016.07.026","article-title":"Cardiovascular risk assessment in patients with rheumatoid arthritis: the relevance of clinical, genetic and serological markers","volume":"15","author":"Lopez-Mejias","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"9410","key":"10.1016\/j.autrev.2017.05.025_bb0015","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)15640-7","article-title":"Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial","volume":"363","author":"Klareskog","year":"2004","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.autrev.2017.05.025_bb0020","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.025_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.10697","article-title":"Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial","volume":"48","author":"Weinblatt","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.025_bb0030","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/ard.2008.101659","article-title":"Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial","volume":"68","author":"Smolen","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.025_bb0035","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/ard.2008.099010","article-title":"Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD study","volume":"68","author":"Keystone","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.autrev.2017.05.025_bb0040","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/1529-0131(199811)41:11<1979::AID-ART13>3.0.CO;2-C","article-title":"Monoclonal expansion of synoviocytes in rheumatoid arthritis","volume":"41","author":"Imamura","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.025_bb0045","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/art.1780390606","article-title":"Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings","volume":"39","author":"Waase","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"20","key":"10.1016\/j.autrev.2017.05.025_bb0050","doi-asserted-by":"crossref","first-page":"10895","DOI":"10.1073\/pnas.94.20.10895","article-title":"Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium","volume":"94","author":"Firestein","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.025_bb0055","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2249.1998.00508.x","article-title":"Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue","volume":"111","author":"Reme","year":"1998","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.025_bb0060","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/rheumatology\/39.3.262","article-title":"Analysis of p53 tumour suppressor gene somatic mutations in rheumatoid arthritis synovium","volume":"39","author":"Inazuka","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.025_bb0065","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.bor.0000160780.13012.be","article-title":"Understanding the genetic contribution to rheumatoid arthritis","volume":"17","author":"van der Helm-van Mil","year":"2005","journal-title":"Curr Opin Rheumatol"},{"issue":"7488","key":"10.1016\/j.autrev.2017.05.025_bb0070","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery","volume":"506","author":"Okada","year":"2014","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.autrev.2017.05.025_bb0075","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","article-title":"The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis","volume":"30","author":"Gregersen","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.025_bb0080","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13075-015-0590-9","article-title":"CD4 T-cell transcriptome analysis reveals aberrant regulation of STAT3 and Wnt signaling pathways in rheumatoid arthritis: evidence from a case-control study","volume":"17","author":"Ye","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.025_bb0085","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nprot.2007.173","article-title":"Collagen-induced arthritis","volume":"2","author":"Brand","year":"2007","journal-title":"Nat Protoc"},{"issue":"10","key":"10.1016\/j.autrev.2017.05.025_bb0090","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.4049\/jimmunol.159.10.5032","article-title":"Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody","volume":"159","author":"Mauri","year":"1997","journal-title":"J Immunol"},{"issue":"6965","key":"10.1016\/j.autrev.2017.05.025_bb0095","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nature02119","article-title":"Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice","volume":"426","author":"Sakaguchi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.05.025_bb0100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1749-6632.2003.tb06042.x","article-title":"Ectopic germinal center formation in rheumatoid synovitis","volume":"987","author":"Weyand","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.025_bb0105","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11926-011-0201-y","article-title":"Synovial tissue heterogeneity and peripheral blood biomarkers","volume":"13","author":"Bugatti","year":"2011","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.025_bb0110","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.autrev.2015.01.001","article-title":"HIV\/AIDS and rheumatoid arthritis","volume":"14","author":"Cunha","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.025_bb0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.autrev.2013.06.008","article-title":"Modulating the co-stimulatory signal for T cell activation in rheumatoid arthritis: could it be the first step of the treatment?","volume":"13","author":"Caporali","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.autrev.2017.05.025_bb0120","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa050524","article-title":"Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition","volume":"353","author":"Genovese","year":"2005","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.autrev.2017.05.025_bb0125","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/ard.2008.101121","article-title":"Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors","volume":"68","author":"Westhovens","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2017.05.025_bb0130","doi-asserted-by":"crossref","first-page":"865","DOI":"10.7326\/0003-4819-144-12-200606200-00003","article-title":"Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial","volume":"144","author":"Kremer","year":"2006","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.025_bb0135","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/annrheumdis-2013-204011","article-title":"Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy","volume":"74","author":"Yun","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.025_bb0140","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/intimm\/8.5.765","article-title":"Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes","volume":"8","author":"Agata","year":"1996","journal-title":"Int Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.025_bb0145","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/intimm\/dxs098","article-title":"PD-1 is a novel regulator of human B-cell activation","volume":"25","author":"Thibult","year":"2013","journal-title":"Int Immunol"},{"issue":"24","key":"10.1016\/j.autrev.2017.05.025_bb0150","doi-asserted-by":"crossref","first-page":"13866","DOI":"10.1073\/pnas.231486598","article-title":"PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine","volume":"98","author":"Okazaki","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2017.05.025_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/nrclinonc.2016.168","article-title":"PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas","author":"Goodman","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.025_bb0160","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.autrev.2017.05.025_bb0165","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/icb.2016.78","article-title":"Germinal centers and autoimmune disease in humans and mice","volume":"94","author":"DeFranco","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.autrev.2017.05.025_bb0170","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fimmu.2016.00430","article-title":"Ectopic lymphoid structures: powerhouse of autoimmunity","volume":"7","author":"Corsiero","year":"2016","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.025_bb0175","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.clim.2014.04.010","article-title":"Programmed death-1 pathway in cancer and autoimmunity","volume":"153","author":"Pedoeem","year":"2014","journal-title":"Clin Immunol"},{"issue":"3950","key":"10.1016\/j.autrev.2017.05.025_bb0180","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1126\/science.169.3950.1042","article-title":"A theory of self-nonself discrimination","volume":"169","author":"Bretscher","year":"1970","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.025_bb0185","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.025_bb0190","doi-asserted-by":"crossref","first-page":"R210","DOI":"10.1186\/ar766","article-title":"The expansion of CD4+CD28\u2212 T cells in patients with rheumatoid arthritis","volume":"5","author":"Pawlik","year":"2003","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.025_bb0195","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2017.05.025_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.162","article-title":"T-cell exhaustion in the tumor microenvironment","volume":"6","author":"Jiang","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.autrev.2017.05.025_bb0205","doi-asserted-by":"crossref","first-page":"174","DOI":"10.14694\/EdBook_AM.2012.32.79","article-title":"Practical management of immune-related adverse events from immune checkpoint protein antibodies for the oncologist","author":"Weber","year":"2012","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.025_bb0210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1074-7613(00)80089-8","article-title":"Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor","volume":"11","author":"Nishimura","year":"1999","journal-title":"Immunity"},{"issue":"5502","key":"10.1016\/j.autrev.2017.05.025_bb0215","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1126\/science.291.5502.319","article-title":"Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice","volume":"291","author":"Nishimura","year":"2001","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.025_bb0220","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00296-009-1249-0","article-title":"The effects of PDL-Ig on collagen-induced arthritis","volume":"31","author":"Wang","year":"2011","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.autrev.2017.05.025_bb0225","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/art.27500","article-title":"The programmed death 1\/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis","volume":"62","author":"Raptopoulou","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.025_bb0230","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/art.20280","article-title":"Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope","volume":"50","author":"Prokunina","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.025_bb0235","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/art.20040","article-title":"Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus","volume":"50","author":"Lin","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.025_bb0240","doi-asserted-by":"crossref","first-page":"247637","DOI":"10.1155\/2014\/247637","article-title":"A promoter region polymorphism in PDCD-1 gene is associated with risk of rheumatoid arthritis in the Han Chinese population of Southeastern China","volume":"2014","author":"Liu","year":"2014","journal-title":"Int J Genomics"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.025_bb0245","first-page":"763","article-title":"Association of programmed cell death-1 (PDCD-1) gene polymorphisms with rheumatoid arthritis in Iranian patients","volume":"29","author":"Tahoori","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.025_bb0250","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/art.11442","article-title":"The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis","volume":"50","author":"Prokunina","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.025_bb0255","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s10038-005-0246-8","article-title":"Ethnic differences in allele frequency of autoimmune-disease-associated SNPs","volume":"50","author":"Mori","year":"2005","journal-title":"J Hum Genet"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.025_bb0260","first-page":"721","article-title":"Ligands for programmed cell death 1 gene in patients with systemic lupus erythematosus","volume":"34","author":"Wang","year":"2007","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.025_bb0265","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10875-007-9113-z","article-title":"Polymorphisms of genes for programmed cell death 1 ligands in patients with rheumatoid arthritis","volume":"27","author":"Wang","year":"2007","journal-title":"J Clin Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2017.05.025_bb0270","first-page":"1410","article-title":"CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid","volume":"30","author":"Hatachi","year":"2003","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.025_bb0275","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s10753-013-9718-8","article-title":"Expression of programmed death-1 (PD-1) on CD4+ and CD8+ T cells in rheumatoid arthritis","volume":"37","author":"Li","year":"2014","journal-title":"Inflammation"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.025_bb0280","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/03009742.2013.823517","article-title":"Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis","volume":"43","author":"Greisen","year":"2014","journal-title":"Scand J Rheumatol"},{"issue":"7639","key":"10.1016\/j.autrev.2017.05.025_bb0285","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.025_bb0290","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.clim.2010.07.012","article-title":"Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity","volume":"137","author":"Liu","year":"2010","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.025_bb0295","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/422827","article-title":"A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis","volume":"75","author":"Begovich","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/j.autrev.2017.05.025_bb0300","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/ng1673","article-title":"Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant","volume":"37","author":"Vang","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2017.05.025_bb0305","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.0105-2896.2004.00211.x","article-title":"Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4","volume":"202","author":"Watford","year":"2004","journal-title":"Immunol Rev"},{"issue":"12","key":"10.1016\/j.autrev.2017.05.025_bb0310","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa073491","article-title":"TRAF1-C5 as a risk locus for rheumatoid arthritis\u2014a genomewide study","volume":"357","author":"Plenge","year":"2007","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.autrev.2017.05.025_bb0315","doi-asserted-by":"crossref","first-page":"8873","DOI":"10.1007\/s11033-012-1754-1","article-title":"Association of STAT4 rs7574865 polymorphism with autoimmune diseases: a meta-analysis","volume":"39","author":"Liang","year":"2012","journal-title":"Mol Biol Rep"},{"issue":"10","key":"10.1016\/j.autrev.2017.05.025_bb0320","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ng.233","article-title":"Common variants at CD40 and other loci confer risk of rheumatoid arthritis","volume":"40","author":"Raychaudhuri","year":"2008","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.025_bb0325","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/anr.1780320104","article-title":"HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes","volume":"32","author":"Nepom","year":"1989","journal-title":"Arthritis Rheum"},{"issue":"24","key":"10.1016\/j.autrev.2017.05.025_bb0330","doi-asserted-by":"crossref","first-page":"10049","DOI":"10.1073\/pnas.86.24.10049","article-title":"HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region","volume":"86","author":"Wordsworth","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.autrev.2017.05.025_bb0335","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/art.10485","article-title":"HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias","volume":"46","author":"Fries","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.025_bb0340","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng.583","article-title":"A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility","volume":"42","author":"Kochi","year":"2010","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.025_bb0345","first-page":"5388","article-title":"Association between CCR6 and rheumatoid arthritis: a meta-analysis","volume":"8","author":"Cheng","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"7","key":"10.1016\/j.autrev.2017.05.025_bb0350","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/rheumatology\/kel023","article-title":"Association between PADI4 and rheumatoid arthritis: a meta-analysis","volume":"45","author":"Iwamoto","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.025_bb0355","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/rheumatology\/keh414","article-title":"Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis","volume":"44","author":"Chang","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.025_bb0360","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/ard.2009.109579","article-title":"Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study","volume":"69","author":"Orozco","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.autrev.2017.05.025_bb0365","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/ard.2008.106393","article-title":"Association of IL2RA and IL2RB with rheumatoid arthritis: a replication study in a Dutch population","volume":"68","author":"Kurreeman","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2017.05.025_bb0370","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/ng.479","article-title":"Genetic variants at CD28, PRDM1 and CD2\/CD58 are associated with rheumatoid arthritis risk","volume":"41","author":"Raychaudhuri","year":"2009","journal-title":"Nat Genet"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T21:17:32Z","timestamp":1750281452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217301490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":74,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1568997217301490"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.05.025","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the programmed cell death-1 pathway in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}